Agilent Technologies Valuation Just Re-Entered 'Buy' Territory

Jun. 27, 2022 12:03 AM ETAgilent Technologies, Inc. (A)DHR, TMO, WAT2 Likes
WideAlpha profile picture


  • For investors who have been waiting to buy shares in Agilent, this is probably a good time to buy at least a starter position.
  • For the last couple of years, Agilent had traded above what fundamentals justified, and now finally shares are priced to deliver very decent 8-9% returns.
  • This is a quality company, with decent growth, and an attractive financial profile.

Electronics Firm Agilent To Sell Chip Unit For $2.66 Billion

Justin Sullivan/Getty Images News

You make most of your money in a bear market; you just don't realize it at the time. Shelby Davis

You rarely get to buy exceptional companies at reasonable valuations, with the exception of bear markets, where even these great investments can become attractive. We believe that is currently the case with Agilent Technologies (NYSE:A), a solid company that has a lot of attractive financial attributes, and which rarely trades at what we would consider an attractive valuation. While we still don't believe shares to be a bargain, we do believe they are now in 'Buy' territory.

Q2 2022 Results

Agilent released solid second quarter results, and management slightly increased its fiscal 2022 bottom line outlook. Sales grew 7% y/y on a core basis (adjusted for currency and acquisitions/divestitures).

The Chinese lockdowns created a 350 basis points headwind in the quarter, as Agilent's Chinese operations were down from late March through the entire month of April. Given the strong underlying demand in China, management believes those sales were not lost and should be realized in calendar 2022.

Agilent Q2 2022 Results

Agilent Technologies Investor Presentation

Competitive Advantages

Agilent has a wide competitive moat derived from a combination of strong intellectual property (patents, trade secrets, etc.), and high switching costs for customers. Once customers are trained to use a given piece of equipment it is a hassle to have to learn to operate another one just because it is slightly cheaper. There are also calibration and maintenance issues that would motivate customers to keep buying from the same supplier. We are encouraged to see that Agilent continues to invest heavily in R&D and that it is not resting in its laurels living off past R&D investments.

Data by YCharts


As sales have been increasing, Agilent has been displaying operating leverage, which has increased the operating margin from an average of ~18% the last five years to ~22% currently. We believe there is room for operating margins to improve further as sales continue to increase.

Data by YCharts

Improved margins and better working capital management have resulted in much higher returns on invested capital, which are now exceeding 15%.

Data by YCharts


In the quarter, Agilent's adjusted EPS grew 16% year over year and has reached $4.15 for the last twelve months. This is almost 2x the lows reached during the worst of the pandemic and puts the price/earnings ratio at ~30x.

Data by YCharts

Revenue growth has not been very constant, but on average has grown ~8.7% over the last five years.

Data by YCharts


In the last five years, Agilent has under-performed competitors Thermo Fisher Scientific (TMO) and Danaher (DHR) with respect total returns delivered to shareholders, but outperformed Waters Corporation (WAT). Part of the reason is that Thermo Fisher and Danaher have been growing revenues at a faster rate, something Agilent will hopefully get better at moving forward.

Data by YCharts

At least Agilent is trading at a cheaper multiple of revenues compared to these competitors, with an EV/Revenues ratio of ~5.8x.

Data by YCharts


Looking at some valuation multiples, we can see that EV/EBITDA is getting close to the ten-year average after a couple of years of trading at much higher valuations.

Data by YCharts

Similarly, the price earnings ratio is finally below 30x, which has not happened since early 2020. The forward p/e is 24x, which we believe is a reasonable multiple for a quality company like Agilent with still some decent amount of growth.

Data by YCharts

Some investors might be disappointed by the low dividend yield, but we would suggest looking at the net common payout yield instead, which combines the dividend yield with the net share repurchases yield.

Data by YCharts

We estimate the net present value of the shares at $108, which is slightly below where shares are currently trading. We were conservative in this calculation, using average earnings estimates for the next three years as compiled by Seeking Alpha, and the assuming 9% growth (in line with growth for the last five years, and not assuming any additional operating leverage). We discounted everything by 10%, but if we use 8% instead, we get $128 per share. We therefore believe that shares are currently priced to deliver ~8-9% returns going forward.

EPS Discounted @ 10%
FY 22E 4.91 4.46
FY 23E 5.38 4.45
FY 24E 6.09 4.58
FY 25E 6.64 4.53
FY 26E 7.24 4.49
FY 27E 7.89 4.45
FY 28E 8.60 4.41
FY 29E 9.37 4.37
FY 30E 10.21 4.33
FY 31E 11.13 4.29
FY 32 E 12.13 4.25
Terminal Value @ 3.5% terminal growth 186.69 59.48
NPV $108.11

FY22 Guidance

For fiscal year 2022 the company is guiding for core revenue growth between 8-9% and EPS between $4.86 and $4.93.

Agilent Technologies FY2022 Guidance

Agilent Technologies Investor Presentation


The main risk we see with Agilent is that of valuation risk. While shares are now trading closer to fair value, there isn't much in the form of margin of safety, and shares could go from having been overvalued to undervalued. In any case the balance sheet is strong, and the company sports a very safe Altman Z-score of 6.36. Short-sellers don't seem to have found anything worrisome with the company as less than 1% of the shares are sold short currently.

Agilent Technologies Risks

Seeking Alpha


For investors who have been waiting to buy shares in Agilent, this is probably a good time to buy at least a starter position. It had been at least a couple of years during which Agilent had been trading above what fundamentals justified, and now finally shares are priced to deliver a very decent 8-9% returns going forward. This is a quality company, with decent growth, and an attractive financial profile.

This article was written by

WideAlpha profile picture
Fin-tech startup leveraging machine learning technology to discover investing opportunities and to generate growth-optimal portfolios. Publisher of the WideAlpha AI-Selected Index, which has markedly outperformed its benchmark.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling shares, you should do your own research and reach your own conclusion, or consult a financial advisor. Investing includes risks, including loss of principal.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.